A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2002
08/07/2002	EP1227736A1 Protein hydrolysates produced with the use of marine proteases
08/07/2002	EP1227734A2 Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein
08/07/2002	EP0986537B1 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
08/07/2002	EP0906276B1 Novel vitamin d analogues
08/07/2002	EP0809517B1 Anti-transforming growth factor-beta gene therapy
08/07/2002	CN1362968A Novel peptides
08/07/2002	CN1362953A Pyrazole compositions useful as inhibitors of ERK
08/07/2002	CN1362952A 2-arylimino-2,3-dihydothiazoles, and their use thereof as somatostain receptor ligands
08/07/2002	CN1362949A 1,5-benzodiazepine derivatives as cck-A receptor agonists
08/07/2002	CN1362947A N-cyanomethylamides as protease inhibitors
08/07/2002	CN1362880A Immunomodulating polymers
08/07/2002	CN1362860A Low-molecular weight polymannuronate
08/07/2002	CN1362859A Ginseng berry health products
08/07/2002	CN1362417A Zinc-binding-force reinforced insulin derivative
08/07/2002	CN1362406A Method for producing one or more kinds of oxydic carotenoid dry powder
08/07/2002	CN1362259A Application of nim extract in medicine
08/07/2002	CN1362250A Health tonic for delaying senility and regualting blood lipoid
08/07/2002	CN1362229A Nano Maiwei Rehmannine Praeparatae medicine and its preparation
08/07/2002	CN1362223A Nano Xinmaitong medicine and its preparation
08/07/2002	CN1362195A Nano Jinkuishenqi medicine for invigorating kidney essence and its preparation
08/07/2002	CN1362165A Nano spirulina medicine and its preparation
08/07/2002	CN1362161A Nano antilipemic Jiangzhiling medicine and its preparation
08/07/2002	CN1362143A Nano diabetes treating medicine and its preparation
08/07/2002	CN1362079A Nano Yuquan medicine and its preparation
08/07/2002	CN1362070A Composite medicine for treating hyperlipemia
08/07/2002	CN1362069A Composite medicine for treating hyperglycaemia
08/07/2002	CN1088572C Haw ice tea drink and its preparing method
08/06/2002	US6429315 Process for preparing N6-substituted adenosine derivatives
08/06/2002	US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis
08/06/2002	US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same
08/06/2002	US6429289 Class BI and CI scavenger receptors
08/06/2002	US6429288 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds
08/06/2002	US6429223 Modified forms of pharmacologically active agents and uses therefor
08/06/2002	US6429214 Inhibitors of bone resorption
08/06/2002	US6429202 Administering complex with phospholipids to prevent atherosclerosis and myocardial or cerebral infarctions; reduces formation of arterial plaques
08/06/2002	US6428990 Conversion of dihomo-gamma-linolenic acid to arachidonic acid and 20:4n-3 to eicosapentaenoic acid by host cell transformed to express human delta5-desaturase enzyme
08/06/2002	US6428954 Method for identifying active domains and amino acid residues in polypeptides and hormone variants
08/06/2002	CA2076060C Compounds named the adenophostins, their preparation and their therapeutic use
08/06/2002	CA1341380C Process for the preparation of n-alkylated amino acids and their esters, use in the synthesis of carboxyalkyl dipeptides
08/01/2002	WO2002059621A2 Regulation of transthyretin to treat obesity
08/01/2002	WO2002059310A2 Polynucleotides encoding cellular transporters and methods of use thereof
08/01/2002	WO2002059308A2 Method of diagnosing and treating cartilage disorders
08/01/2002	WO2002059304A1 Novel g protein-coupled receptor protein and dna thereof
08/01/2002	WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor
08/01/2002	WO2002059286A2 Adenylate cyclases
08/01/2002	WO2002059278A2 Differentiation of stem cells to pancreatic endocrine cells
08/01/2002	WO2002059267A2 Constitutively desensitized g protein-coupled receptors
08/01/2002	WO2002059129A2 Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists
08/01/2002	WO2002059127A2 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
08/01/2002	WO2002059124A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
08/01/2002	WO2002059117A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
08/01/2002	WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002	WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002	WO2002059108A1 Melanocortin receptor agonists
08/01/2002	WO2002059107A1 Substituted piperidines/piperazines as melanocortin receptor agonists
08/01/2002	WO2002059102A2 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use
08/01/2002	WO2002059098A1 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
08/01/2002	WO2002059095A1 Melanocortin receptor agonists
08/01/2002	WO2002059088A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
08/01/2002	WO2002059087A1 Preparation of non-crystalline atorvastatin calcium
08/01/2002	WO2002059083A2 Novel compounds
08/01/2002	WO2002059082A2 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands
08/01/2002	WO2002059080A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
08/01/2002	WO2002058734A2 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
08/01/2002	WO2002058733A2 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
08/01/2002	WO2002058732A2 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
08/01/2002	WO2002058731A2 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
08/01/2002	WO2002058729A2 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies
08/01/2002	WO2002058724A2 Use of lp82 to treat body weight disorders
08/01/2002	WO2002058715A1 Prevention of diabetes by administration of gnrh antagonists
08/01/2002	WO2002058707A2 Method of treatment of type i diabetes with vitamin d compounds
08/01/2002	WO2002058704A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors
08/01/2002	WO2002058702A1 Urotensin-ii receptor antagonists
08/01/2002	WO2002058698A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/01/2002	WO2002058696A2 The use of substituted azetidinone compounds for the treatment of sitosterolemia
08/01/2002	WO2002058690A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
08/01/2002	WO2002058685A2 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
08/01/2002	WO2002058532A2 Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof
08/01/2002	WO2002042278A3 Imidazole and benzimidazole caspase inhibitors and uses thereof
08/01/2002	WO2002038646A3 Novel polyesters, method for producing the same and depot medicaments produced from these polyesters
08/01/2002	WO2002022572A3 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
08/01/2002	WO2002022166A3 Tweak receptor agonists as anti-angiogenic agents
08/01/2002	WO2002016620A3 Modulation of stem cell differentiation
08/01/2002	WO2002014477A3 Bioavailable composition of natural and synthetic hca
08/01/2002	WO2002014319A3 Heterocyclic compounds useful as inhibitors of tyrosine kinases
08/01/2002	WO2002012227A3 Indole, azaindole and indazole derivatives having vegf inhibiting activity
08/01/2002	WO2002008285A3 Il-17 molecules and uses thereof
08/01/2002	WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same
08/01/2002	WO2001098279A3 Bis-arylsulfones
08/01/2002	WO2001096565A3 Binding agents: chimeric ligand/receptor proteins
08/01/2002	WO2001095916A3 Anticholestatic medicament containing luteolin-7-o-glucuronide
08/01/2002	WO2001091587A3 Oil compositions comprising short, medium and long chain triglycerides and use thereof in reducing weight gain
08/01/2002	WO2001089536A3 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
08/01/2002	WO2001089319A3 Tryptophan source from plants and uses therefor
08/01/2002	WO2001083527A3 Glucagon antagonists
08/01/2002	WO2001082953A3 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
08/01/2002	WO2001072836A3 G-protein coupled receptors
08/01/2002	WO2001070738A3 Tri-aryl-substituted-ethane pde4 inhibitors
08/01/2002	US20020104113 Nav2 channel gene-deficient non-human animals
08/01/2002	US20020103337 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof

1 ... 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 ... 1298